Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+ T cells.

Cupovic, Jovana; Ring, Sandra S; Onder, Lucas; Colston, Julia M; Lütge, Mechthild; Cheng, Hung-Wei; De Martin, Angelina; Provine, Nicholas M; Flatz, Lukas; Oxenius, Annette; Scandella, Elke; Krebs, Philippe; Engeler, Daniel; Klenerman, Paul; Ludewig, Burkhard (2021). Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+ T cells. Nature immunology, 22(8), pp. 1042-1051. Nature Publishing Group 10.1038/s41590-021-00969-3

[img] Text
s41590-021-00969-3.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (19MB)

Pathogens and vaccines that produce persisting antigens can generate expanded pools of effector memory CD8+ T cells, described as memory inflation. While properties of inflating memory CD8+ T cells have been characterized, the specific cell types and tissue factors responsible for their maintenance remain elusive. Here, we show that clinically applied adenovirus vectors preferentially target fibroblastic stromal cells in cultured human tissues. Moreover, we used cell-type-specific antigen targeting to define critical cells and molecules that sustain long-term antigen presentation and T cell activity after adenovirus vector immunization in mice. While antigen targeting to myeloid cells was insufficient to activate antigen-specific CD8+ T cells, genetic activation of antigen expression in Ccl19-cre-expressing fibroblastic stromal cells induced inflating CD8+ T cells. Local ablation of vector-targeted cells revealed that lung fibroblasts support the protective function and metabolic fitness of inflating memory CD8+ T cells in an interleukin (IL)-33-dependent manner. Collectively, these data define a critical fibroblastic niche that underpins robust protective immunity operating in a clinically important vaccine platform.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Immunopathology

UniBE Contributor:

Krebs, Philippe

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1529-2908

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Philippe Krebs

Date Deposited:

26 Aug 2021 17:36

Last Modified:

05 Dec 2022 15:52

Publisher DOI:

10.1038/s41590-021-00969-3

PubMed ID:

34267375

BORIS DOI:

10.48350/157987

URI:

https://boris.unibe.ch/id/eprint/157987

Actions (login required)

Edit item Edit item
Provide Feedback